We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

24 Jul 2026 - 26 Jul 2026
05 Aug 2026 - 07 Aug 2026

First US Use of Patient's Own Stem Cells to Repair Heart

By HospiMedica staff writers
Posted on 24 Mar 2003
For the first time in the United States, doctors have used bone marrow stem cells from a patient's own blood to repair heart damage resulting from a heart attack. More...
The doctors hope the stem cells will regenerate damaged heart tissue and stimulate the growth of new blood vessels.

The patient, a boy of 16, suffered a massive heart attack caused by swelling that caused pressure on his coronary artery, leaving him with no option but a heart transplant. By coincidence, doctors at the hospital had been preparing for a clinical trial of stem cells. The experimental treatment began with putting the patient on a four-day regimen of a drug (Neupogen) that stimulates the production of stem cells. Four days later, they harvested the patient's stem cells with a special blood collection machine, then used a heart catheter to transplant the stem cells into the patient's left anterior descending artery, which supplies blood to the heart.

Although there is no proof as yet that the therapy is working, doctors report that the patient's ejection fraction, which had fallen from 65-25%, rose to 35% several days after the operation. Positron emission tomography (PET) scans taken prior to the procedure showed no viable heart muscle in the area affected. The doctors plan to take another scan in three months to determine if new muscle is shown there as a result of the treatment.

"The transplant went exactly as planned, lasting less than 60 minutes,” says Steven Timmis, M.D., who performed the stem cell transplant at Beaumont Hospital in Royal Oak (MI, USA). "Dimitri tolerated the treatment very well, experiencing no complications.”




Related Links:
Beaumont Hospitals

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Gas Analyzer
GE SAM
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.